HDFC Pharma and Healthcare Fund
HDFC Mutual Fund · FM: Dhruv Muchhal, Nikhil Mathur · INF179KC1HO1 · Direct
NAV ₹22.69 AUM ₹2611 Cr as of 22 Sep 2026
Latest available portfolio · Retrieved: 8-Aug-2026 11:47 PM IST · Disclosure date not provided
Returns
| 1D | 1M | 3M | 6M | 1Y | 3Y | 5Y | Rank (1Y) | TER | |
|---|---|---|---|---|---|---|---|---|---|
| Fund | -0.9% | +1.7% | +9.1% | +30.2% | +27.3% | — | — | 5/234 | 1.03% |
Equity allocation
97.25%
Non-equity allocation (combined)
2.75%
All Equity Holdings (35) latest available
| # | Company | Value (₹ Cr) | % of AUM | Change |
|---|---|---|---|---|
| 1 | Sun Pharmaceuticals Industries Ltd | 260.0 | 9.96% | — |
| 2 | Divi's Laboratories Ltd | 186.9 | 7.16% | — |
| 3 | Max Healthcare Institute Ltd Ordinary Shares | 145.5 | 5.57% | — |
| 4 | Lupin Ltd | 137.5 | 5.26% | — |
| 5 | Cipla Ltd | 135.6 | 5.19% | — |
| 6 | Aster DM Quality Care Ltd Ordinary Shares | 131.9 | 5.05% | — |
| 7 | Acutaas Chemicals Ltd | 119.5 | 4.58% | — |
| 8 | Alkem Laboratories Ltd | 104.4 | 4.00% | — |
| 9 | Anthem Biosciences Ltd | 99.5 | 3.81% | — |
| 10 | Ipca Laboratories Ltd | 92.2 | 3.53% | — |
| 11 | Fortis Healthcare Ltd | 83.0 | 3.18% | — |
| 12 | Global Health Ltd | 80.4 | 3.08% | — |
| 13 | Krishna Institute of Medical Sciences Ltd | 80.2 | 3.07% | — |
| 14 | Neuland Laboratories Ltd | 76.6 | 2.93% | — |
| 15 | Glenmark Pharmaceuticals Ltd | 75.1 | 2.88% | — |
| 16 | Vijaya Diagnostic Centre Ltd | 66.0 | 2.53% | — |
| 17 | Shilpa Medicare Ltd | 64.7 | 2.48% | — |
| 18 | Zydus Lifesciences Ltd | 61.1 | 2.34% | — |
| 19 | Metropolis Healthcare Ltd | 58.4 | 2.24% | — |
| 20 | Wockhardt Ltd | 55.0 | 2.11% | — |
| 21 | Sai Life Sciences Ltd | 44.7 | 1.71% | — |
| 22 | Rubicon Research Ltd | 44.5 | 1.70% | — |
| 23 | Thyrocare Technologies Ltd | 39.5 | 1.51% | — |
| 24 | Eris Lifesciences Ltd Registered Shs | 38.9 | 1.49% | — |
| 25 | Ajanta Pharma Ltd | 37.0 | 1.42% | — |
| 26 | Corona Remedies Ltd | 34.1 | 1.31% | — |
| 27 | Gland Pharma Ltd | 31.2 | 1.20% | — |
| 28 | Jubilant Pharmova Ltd | 30.8 | 1.18% | — |
| 29 | Biocon Ltd | 30.7 | 1.17% | — |
| 30 | Dr Reddy's Laboratories Ltd | 27.1 | 1.04% | — |
| 31 | Bajaj Healthcare Ltd | 20.0 | 0.77% | — |
| 32 | Laxmi Dental Ltd | 14.5 | 0.56% | — |
| 33 | Novartis India Ltd | 13.9 | 0.53% | — |
| 34 | Cohance Lifesciences Ltd | 11.4 | 0.44% | — |
| 35 | Jupiter Life Line Hospitals Ltd | 7.1 | 0.27% | — |
All disclosed equity positions are shown. Non-equity allocation is the remaining portfolio weight after disclosed equities.